These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 38390594)

  • 21. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post-COVID Syndrome: A Common Neuroimmune Ground?
    Ryabkova VA; Gavrilova NY; Fedotkina TV; Churilov LP; Shoenfeld Y
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Campen CLMCV; Rowe PC; Visser FC
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056336
    [No Abstract]   [Full Text] [Related]  

  • 23. Stellate ganglion block reduces symptoms of Long COVID: A case series.
    Liu LD; Duricka DL
    J Neuroimmunol; 2022 Jan; 362():577784. PubMed ID: 34922127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature.
    Komaroff AL; Lipkin WI
    Front Med (Lausanne); 2023; 10():1187163. PubMed ID: 37342500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of Long COVID symptoms over one year.
    Oliveira CR; Jason LA; Unutmaz D; Bateman L; Vernon SD
    Front Med (Lausanne); 2022; 9():1065620. PubMed ID: 36698810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome.
    Novak P; Giannetti MP; Weller E; Hamilton MJ; Mukerji SS; Alabsi HS; Systrom D; Marciano SP; Felsenstein D; Mullally WJ; Pilgrim DM; Castells M
    Neurol Sci; 2022 Dec; 43(12):6627-6638. PubMed ID: 36169757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination.
    Gómez-Moyano E; Rodríguez-Capitán J; Gaitán Román D; Reyes Bueno JA; Villalobos Sánchez A; Espíldora Hernández F; González Angulo GE; Molina Mora MJ; Thurnhofer-Hemsi K; Molina-Ramos AI; Romero-Cuevas M; Jiménez-Navarro M; Pavón-Morón FJ
    Front Neurol; 2023; 14():1221518. PubMed ID: 37654428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lyme disease and the pursuit of a clinical cure.
    Adkison H; Embers ME
    Front Med (Lausanne); 2023; 10():1183344. PubMed ID: 37293310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis.
    Taylor K; Pearson M; Das S; Sardell J; Chocian K; Gardner S
    J Transl Med; 2023 Nov; 21(1):775. PubMed ID: 37915075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
    Wong KH; Shapiro ED; Soffer GK
    Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-Acute Sequelae of COVID-19 (PASC) in Pediatrics: Factors That Impact Symptom Severity and Referral to Treatment.
    Soprano CM; Ngo R; Konys CA; Bazier A; Salamon KS
    Children (Basel); 2023 Nov; 10(11):. PubMed ID: 38002896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome.
    Paul BD; Lemle MD; Komaroff AL; Snyder SH
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34400495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 Dysautonomia.
    Goodman BP; Khoury JA; Blair JE; Grill MF
    Front Neurol; 2021; 12():624968. PubMed ID: 33927679
    [No Abstract]   [Full Text] [Related]  

  • 34. Cerebral blood flow remains reduced after tilt testing in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    van Campen CLMC; Rowe PC; Visser FC
    Clin Neurophysiol Pract; 2021; 6():245-255. PubMed ID: 34667909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of SARS-CoV-2: More in Common Than Not?
    Joseph P; Singh I; Oliveira R; Capone CA; Mullen MP; Cook DB; Stovall MC; Squires J; Madsen K; Waxman AB; Systrom DM
    Chest; 2023 Sep; 164(3):717-726. PubMed ID: 37054777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Post-COVID-19 dysautonomia: a case report.
    Bosco J; Titano R
    BMC Infect Dis; 2022 Mar; 22(1):214. PubMed ID: 35241011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation, neuroglial dysfunction, and plasmalogen deficiency as a new pathobiological hypothesis addressing the overlap between post-COVID-19 symptoms and myalgic encephalomyelitis/chronic fatigue syndrome.
    Chaves-Filho AM; Braniff O; Angelova A; Deng Y; Tremblay MÈ
    Brain Res Bull; 2023 Sep; 201():110702. PubMed ID: 37423295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoimmunity against a glycolytic enzyme as a possible cause for persistent symptoms in Lyme disease.
    Maccallini P; Bonin S; Trevisan G
    Med Hypotheses; 2018 Jan; 110():1-8. PubMed ID: 29317049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medically Documenting Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Cases.
    Comerford BB; Podell R
    Front Pediatr; 2019; 7():231. PubMed ID: 31334205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long COVID: mechanisms, risk factors and recovery.
    Astin R; Banerjee A; Baker MR; Dani M; Ford E; Hull JH; Lim PB; McNarry M; Morten K; O'Sullivan O; Pretorius E; Raman B; Soteropoulos DS; Taquet M; Hall CN
    Exp Physiol; 2023 Jan; 108(1):12-27. PubMed ID: 36412084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.